Product
Topical 4-OHT gel
1 clinical trial
3 indications
Indication
Breast Atypical HyperplasiaIndication
Lobular Carcinoma in SituIndication
Atypical lobular hyperplasiaClinical trial
A Phase IIB Randomized Trial of Oral Tamoxifen vs. Topical 4-hydroxytamoxifen Gel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In SituStatus: Recruiting, Estimated PCD: 2026-12-31